A drug that stops cancer treatments damaging ovaries could preserve patients’
fertility. Researchers at the Memorial Sloan-Kettering Cancer Center and
Massachusetts General Hospital injected a compound called
sphingosine-1-phosphate into the ovaries of mice. This prevented a lipid in the
membrane of an egg cell being converted into another lipid called ceramide and
starting a chain reaction that ends in cell suicide (Nature Medicine,
vol 6, p 1109). “If they have stopped [cell death] and produced normal embryos
from the ovaries, this is fantastic,” says Geraldine Hartshorne of the University of Warwick.
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓÆµ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓÆµ articles
1
The best new science-fiction books of June 2026
2
Pancreatic cancer halted by virus injection in three patients
3
Photons behave very strangely if you try to cut them
4
3D-printed lymph nodes could widen access to CAR T-cell therapy
5
How a radical new view of life could reveal its origin – and aliens
6
Our verdict on Luminous by Silvia Park: a fascinating take on robots
7
Wealthy people with environmental ideals are the biggest emitters
8
How I used psychology to come back from the worst year of my life
9
Start-ups are racing to revolutionise mathematics with AI
10
Embryos made without sperm or eggs reveal why many pregnancies fail



